Anyuan Pharmaceuticals

Strategic-Round
ampsourcebio.com Biotech & Healthcare Shanghai
Total Funding $33.0M
Latest Round $33M Strategic-Round
Last Announced Oct 29, 2026
Investors 1 Backer
Decision Makers Profile Active

About Anyuan Pharmaceuticals

Anyuan Pharmaceutical Technology (Shanghai) develops biological macromolecular drugs.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Strategic-Round
Global Headquarters Shanghai
Tracked Since Oct 29, 2026

Web & Domain Identity

Official Website ampsourcebio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $33,020,000 · Strategic-Round

    Backed by North China Pharmaceutical Group Corporation

Investors & Backers

1
North China Pharmaceutical Group Corporation
Lead

Funding History

1 Round
Strategic-Round equity · Oct 29, 2026

Round backers: North China Pharmaceutical Group Corporation

$33,020,000 ifastdata.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts